| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 1578EUB98L |
| InChI Key | FECGNJPYVFEKOD-VMPITWQZSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C16H19N3O4S |
| Molecular Weight | 349.41 |
| AlogP | 1.31 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 91.64 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 24.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class I
|
- | 43-877 | - | - | - | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | 72-72 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Carcinoma, Hepatocellular | 2 | D006528 | ClinicalTrials |
| Sezary Syndrome | 2 | D012751 | ClinicalTrials |
| Mycosis Fungoides | 2 | D009182 | ClinicalTrials |
| Hodgkin Disease | 2 | D006689 | ClinicalTrials |
| Colorectal Neoplasms | 1 | D015179 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 864814-88-0 |
| ChEMBL | CHEMBL4296717 |
| DrugBank | DB12392 |
| EPA CompTox | DTXSID50235587 |
| FDA SRS | 1578EUB98L |
| Guide to Pharmacology | 7502 |
| PDB | P7D |
| PubChem | 11609955 |
| SureChEMBL | SCHEMBL295540 |
| ZINC | ZINC000013983495 |